Article

Are clear corneal incisions safe? Veteran practitioner says 'yes'

Properly constructed clear corneal incisions can ensure immediate sealing following phacoemulsification and are a key component in endophthalmitis prophylaxis, according to I. Howard Fine, MD. Dr. Fine, clinical professor of ophthalmology at Casey Eye Institute, Oregon Health & Science University, Portland, spoke during the Innovator's Session.

Properly constructed clear corneal incisions can ensure immediate sealing following phacoemulsification and are a key component in endophthalmitis prophylaxis, according to I. Howard Fine, MD. Dr. Fine, clinical professor of ophthalmology at Casey Eye Institute, Oregon Health & Science University, Portland, spoke during the Innovator's Session.

Since 1992, Dr. Fine, has utilized a single-plane incision technique to create 2-mm long and 2.5-mm wide incisions. Recently, Dr. Fine and his colleagues, Richard S. Hoffman, MD, and Mark Packer, MD, studied these incisions with optical coherence tomography (OCT). They found the single-plane incision to be arcuate and longer than the chord length, producing a tongue-and-groove architecture (similar to paneling). They also discovered that stromal hydration persisted for longer than 24 hours.

Side-port incisions also were analyzed with OCT. Different blades and incision sizes were studied, indicating that these tools provide good architecture if the incision is properly constructed.

With more than 10 years' experience and greater than 10,000 cases completed with no endophthalmitis, Dr. Fine said he is confident that clear corneal incisions are safe and effective for cataract surgery.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.